Testing effectiveness (Phase 2)Study completedNCT00940225What this trial is testingStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesWho this might be right forSolid TumorsCancer Exelixis 730
Testing effectiveness (Phase 2)Ended earlyNCT03519178What this trial is testingPF-06873600 in People With CancerWho this might be right forHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer Pfizer 155
Large-scale testing (Phase 3)Active Not RecruitingNCT04639986What this trial is testingAsian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)Who this might be right forMetastatic Breast Cancer Gilead Sciences 331
Testing effectiveness (Phase 2)Study completedNCT00593827What this trial is testingPhase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer R-Pharm 176
Not applicableStudy completedNCT05505175What this trial is testingOutcomes Among Patients in Brazil Receiving Palbociclib Combinations for HR+/HER2- MBCWho this might be right forBreast CancerBreast Carcinoma Pfizer 120
Not applicableStudy completedNCT03730428What this trial is testingEverolimus Related Pneumonitis in MBCWho this might be right forEverolimusPneumonitis Fudan University 86
Testing effectiveness (Phase 2)Study completedNCT00532272What this trial is testingGoserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBCWho this might be right forMetastatic Breast Cancer National Cancer Center, Korea 78
Testing effectiveness (Phase 2)Looking for participantsNCT05693766What this trial is testingGene Signatures to Guide HR+MBC Therapy in a Diverse CohortWho this might be right forInvasive Mammary CarcinomaMetastatic Breast Cancer Sonya Reid 64
Not applicableStudy completedNCT06961331What this trial is testingReal World-clinical Outcomes of Tucatinib, Trastuzumab, and Capecitabine Following Trastuzumab Deruxtecan (T-DXd) for the Treatment of HER2-positive Metastatic Breast Cancer.Who this might be right forMetastatic HER2+ Advanced Breast Cancer Pfizer 86
Early research (Phase 1)Study completedNCT00932373What this trial is testingTrastuzumab-MCC-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer Who Have Previously Received a Trastuzumab-Containing RegimenWho this might be right forMetastatic Breast Cancer Genentech, Inc. 54
Not applicableLooking for participantsNCT06855654What this trial is testingPromoting Resilience in Women With Breast Cancer (PRISM -MBC)Who this might be right forBreast CancerMetastatic Breast Cancer UNC Lineberger Comprehensive Cancer Center 120
Testing effectiveness (Phase 2)Study completedNCT01306942What this trial is testingDasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC PatientsWho this might be right forMetastatic Breast Cancer Spanish Breast Cancer Research Group 37
Early research (Phase 1)Study completedNCT00928330What this trial is testingTrastuzumab and Trastuzumab-MCC-DM1 Administered Intravenously and GDC-0941 Administered Orally to Patients With HER2-Positive Metastatic Breast Cancer Who Have Progressed on Previous Trastuzumab-Based TherapyWho this might be right forMetastatic Breast Cancer Genentech, Inc. 57
Early research (Phase 1)Looking for participantsNCT06784193What this trial is testingPhase 1 Study of OP-3136 in Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic ER+ HER2- Breast Cancer (mBC)Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC)+3 more Olema Pharmaceuticals, Inc. 180
Testing effectiveness (Phase 2)Ended earlyNCT03070002What this trial is testingDenosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor CellsWho this might be right forBreast Carcinoma Metastatic in the BoneCirculating Tumor Cell CountEstrogen Receptor Positive+3 more Northwestern University 1
Large-scale testing (Phase 3)Study completedNCT01619111What this trial is testingDETECT III - A Multicenter, Phase III Study to Compare Standard Therapy +/- Lapatinib in HER2-ve MBC-Patients With HER2+ve CTCsWho this might be right forHER2-negative Metastatic Breast CancerHER2-positive Circulating Tumor Cells Prof. Wolfgang Janni 105
Testing effectiveness (Phase 2)Study completedNCT02659514What this trial is testingStudy of Poziotinib in Participants With HER2-Positive Metastatic Breast CancerWho this might be right forBreast Cancer Spectrum Pharmaceuticals, Inc 67
Not applicableStudy completedNCT00876070What this trial is testingCommunity Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer SCRI Development Innovations, LLC 198
Testing effectiveness (Phase 2)Study completedNCT00442260What this trial is testingDoxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer West Virginia University 2
Testing effectiveness (Phase 2)Ended earlyNCT01036113What this trial is testingEZN-2208 in Patients With Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Enzon Pharmaceuticals, Inc. 160